Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease

Autor(es)

Cavalcante, Isadora P. ; Berthon, Annabel ; Fragoso, Maria C. ; Reincke, Martin ; Stratakis, Constantine A. ; Ragazzon, Bruno ; Bertherat, Jerome

• Tipo de documento: Artigo Científico
• Fonte: NATURE REVIEWS ENDOCRINOLOGY; v. 18, n. 11, p. 13-pg., 2022-08-03.

Resumo

Primary bilateral macronodular adrenal hyperplasia (PBMAH) is an adrenal cause of Cushing syndrome. Nowadays, a PBMAH diagnosis is more frequent than previously, as a result of progress in the diagnostic methods for adrenal incidentalomas, which are widely available. Although some rare syndromic forms of PBMAH are known to be of genetic origin, non-syndromic forms of PBMAH have only been recognized as a genetic disease in the past 10 years. Genomics studies have highlighted the molecular heterogeneity of PBMAH and identified molecular subgroups, allowing improved understanding of the clinical heterogeneity of this disease. Furthermore, the generation of these subgroups permitted the identification of new genes responsible for PBMAH. Constitutive inactivating variants in ARMC5 and KDM1A are responsible for the development of distinct forms of PBMAH. To date, pathogenic variants of ARMC5 are responsible for 20-25% of PBMAH, whereas germline KDM1A alterations have been identified in >90% of PBMAH causing food-dependent Cushing syndrome. The identification of pathogenic variants in ARMC5 and KDM1A demonstrated that PBMAH, despite mostly being diagnosed in adults aged 45-60 years, is a genetic disorder. This Review summarizes the important progress made in the past 10 years in understanding the genetics of PBMAH, which have led to a better understanding of the pathophysiology, opening new clinical perspectives. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) is an adrenal cause of Cushing syndrome. This Review outlines recent progress in understanding the genetics of PBMAH. (AU)

• Processo FAPESP: 15/50192-9 - Avanços na compreensão da fisiopatologia da hiperplasia macronodular adrenocortical primária - PMAH (GP-PMAH)
• Beneficiário: Maria Candida Barisson Villares Fragoso
• Modalidade de apoio: Auxílio à Pesquisa - Temático